Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Contracts + Grants

    DARPA BRICS Synthetic Biology Proposers’ Conference

    By Global Biodefense StaffJuly 30, 2014
    Share
    Facebook LinkedIn Reddit Email

    The development of increasingly sophisticated techniques and tools to sequence, synthesize and manipulate genetic material has led to the rapidly maturing discipline of synthetic biology.

    To date, work in synthetic biology has focused primarily on manipulating individual species of domesticated organisms to perform specific tasks, such as producing medicines or fuels.

    These species tend to be both relatively fragile (requiring precise environmental conditions to survive) and relatively unstable (subject to losing their engineered advantages through genetic attrition or recombination). The costs of maintaining required environmental controls and detecting and compensating for genetic alterations are substantial and severely limit the widespread application of synthetic biology to U.S. national security missions.

    To help address these challenges, DARPA has created the Biological Robustness in Complex Settings (BRICS) program. BRICS seeks to develop the fundamental understanding and component technologies needed to increase the biological robustness and stability of engineered organisms while maintaining or enhancing the safe application of those organisms in complex biological environments. The goal is to create the technical foundation for future engineered biological systems to achieve greater biomedical, industrial and strategic potential.

    “By making these systems more robust, stable and safe, BRICS seeks to harness the full range of capabilities at the intersection of engineering and biology,” said Justin Gallivan, DARPA program manager. “These capabilities could include efficient on-demand bio-production of novel drugs, fuels, sensors and coatings; or engineered microbes able to optimize human health by treating or preventing disease.”

    To familiarize potential participants with the technical objectives of BRICS, DARPA has scheduled a Proposers’ Day on Thursday, August 21, 2014, at the Capital Conference Center in Arlington, VA.

    The goals of the Proposers’ Day are:

    • To introduce the science and technology community (industry, academia, and government) to the BRICS program vision and goals;
    • To facilitate interaction between investigators that may have capabilities to develop elements of interest and relevance to the BRICS goals; and
    • To encourage and promote teaming arrangements among organizations that have the relevant expertise, research facilities and capabilities for executing research and development responsive to the BRICS program goals.

    The event will include overview presentations by government personnel and provide opportunities for team building among the participants.

    Advance registration is required prior to August 18, 2014. The full Broad Agency Announcement for BRICS is expected to be released prior to the Proposers’ Day. (Editor’s Update: The BRICS BAA was released August 12, 2014.)

    A key goal of the program is to understand the dynamics that influence stability, robustness and safety in complex biological environments. Once the components and interactions comprising those dynamics are adequately understood, DARPA intends to support an integration team that would use the developed methods and tools to build a contained multi-species system that embodies all the attributes required to operate in a complex setting at scale.

    While the technologies that BRICS aims to help develop could find eventual application in non-laboratory settings—including, for example, the human gastrointestinal tract or complex mechanical or chemical environments where biologically based sensors or films might be useful—all work performed in this program will occur in controlled laboratory settings.

    Proposals that include efforts to manipulate or study genetically modified organisms in open ecosystems or in any context not completely insulated from the natural environment will not be considered. Proposers must ensure and demonstrate throughout the program that all methods and demonstrations of capability comply with all applicable federal, state, and local regulations for manipulation of genes and organisms and follow all guidance for biological safety and biosecurity.

    Sources: DARPA press release, FBO.gov solicitation. Image courtesy of DARPA.

    BAA Biosafety DARPA Events Synthetic Biology
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleNIAID Creating Quantitative Viral Outgrowth Assay Service
    Next Article MAPP Biopharmaceutical Awarded Funding for Ebola Drug

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023

    NIAID Seeks to Improve Computational Models of Influenza Immunity

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.